House user fee reauthorization a platform for FDA reform

Congress took a big step forward Wednesday toward reauthorizing FDA user fees and setting parameters for FDA reforms.

The House Energy and Commerce Committee has reached bipartisan agreement on user fee reauthorization legislation that would create requirements for clinical trials diversity, strengthen FDA’s power to require confirmatory trials of drugs that receive accelerated approval, and incentivize advanced manufacturing. ...